Skip to main content
SpringerLink
Log in
Book cover

Autoimmune Diseases of the Skin pp 71–93Cite as

Bullous Pemphigoid: Clinical Features, Diagnostic Markers, and Immunopathogenic Mechanisms

  • Chapter

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Andrä K, Lassmann H, Bittner R, Shorny S, Fässler R, Propst F, Wiche G (1997) Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture. Gen Develop 11: 3143–3156

    Google Scholar 

  • Anhalt GJ, Diaz LA (1987) Animal models for bullous pemphigoid. Clin Dermatol 5: 117–125

    Article  PubMed  Google Scholar 

  • Balding SD, Prost C, Diaz LA, Bernard P, Bedane C, Aberdam D, Giudice GJ (1996) Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol 106: 141–146

    Article  PubMed  Google Scholar 

  • Banfield CC, Wojnarowska F, Allen J, George S, Venning VA, Welsh KI (1998) The association of HLA-DQ7 with bullous pemphigoid is restricted to men. Br J Dermatol 138: 1085–1090

    Article  PubMed  Google Scholar 

  • Bastuji-Garin S, Joly P, Picard-Dahan C, Bernard P, Vaillant L, Pauwels C, Salagnac V, Lok C, Roujeau JC (1996) Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol 132: 272–276

    Article  PubMed  Google Scholar 

  • Bernard P, Didierjean L, Denis F, Saurat JH, Bonnetblanc JM (1989) Heterogeneous bullous pemphigoid antibodies: detection and characterization by immunoblotting when absent by indirect immunofluorescence. J Invest Dermatol 92: 171–174

    Article  PubMed  Google Scholar 

  • Bernard P, Prost C, Lecerf V, Intrator L, Combemale P, Bedane C, Roujeau JC, Revuz J, Bonnetblanc JM, Dubertret L (1990a) Studies of cicatricial pemphigoid autoantibodies using direct immunelectron microscopy and immunoblot analysis. J Invest Dermatol 94: 630–635

    Article  PubMed  Google Scholar 

  • Bernard P, Aucouturier P, Denis F, Bonnetblanc JM (1990b) Immunoblot analysis of IgG subclass of circulating antibodies in bullous pemphigoid. Clin Immunol Immunopath 54: 484–494

    Article  Google Scholar 

  • Bernard P, Vaillant L, Labeille B, Bedane C, Arbeille B, Denoeux JP, Lorette G, Bonnetblanc JM, Prost C (1995) Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous diseases French study group. Arch Dermatol 131: 48–52

    Article  PubMed  Google Scholar 

  • Bernard P, Bedane C, Bonnetblanc JM (1997) Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients. Br J Dermatol 136: 694–698

    PubMed  Google Scholar 

  • Borradori L, Koch PJ, Niessen CM, Erkeland S, van Leusden M, Sonnenberg A (1997) The localization of bullous pemphigoid antigen 180 (BP180) in hemidesmosomes is mediated by its cytoplasmic domain and seems to be regulated by the b4 integrin subunit. J Cell Biol 136: 1333–1347

    Article  PubMed  Google Scholar 

  • Borradori L, Sonnenberg A (1999) Structure and function of hemidesmosomes: more than simple adhesion complexes. J Invest Dermatol 112: 411–418

    Article  PubMed  Google Scholar 

  • Büdinger L, Borradori L, Yee C, Eming R, Ferencik S, Grosse-Wilde H, Merk HF, Yancey K, Hertl M (1998) Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest 102: 2082–2089

    PubMed  Google Scholar 

  • Burton JL, Harman RM, Peachey RD, Warin RP (1978) A controlled trial of azathioprine in the treatment of pemphigoid. Br J Dermatol 99(Suppl 16):14

    PubMed  Google Scholar 

  • Briggaman RA, Gammon WR, Woodley DT (1985) Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid). J Invest Dermatol. 85:79s–84s

    Article  PubMed  Google Scholar 

  • Chan LS, Yancey KB, Hammerberger C, Soong HK, Regezi JA, Johnson K, Cooper KD (1993). Immune-mediated subepithelial blistering diseases of mucous membranes. Arch Dermatol 129: 448–455

    Article  PubMed  Google Scholar 

  • Chan LS, Majmudar AA, Tran HH, Meier F, Schaumburg-Lever G, Chen M, Woodley DT, Marinkovich PM (1997) Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid. J Invest Dermatol 108: 848–853

    Article  PubMed  Google Scholar 

  • Chen R, Ning G, Zhao ML, Fleming MG, Diaz LA, Werb Z, Liu Z (2001) Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest; 108(8):1151–8

    Article  PubMed  Google Scholar 

  • Chen R, Fairley JA, Zhao ML, Giudice GJ, Zillikens D, Diaz LA, Liu Z (2002) Macrophages, but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: macrophage-mediated neutrophilinfiltration depends on mast cell activation. J Immunol. 2002 Oct 1; 169(7):3987–92.

    PubMed  Google Scholar 

  • Chosidow O, Doppler V, Bensimon G, Joly P, Salachas F, Lacomblez L, Prost C, Camu W, Frances C, Herson S, Meininger V (2000) Bullous pemphigoid and myotrophic lateral sclerosis: a new clue for understanding the bullous disease? Arch Dermatol 136: 521–524.

    Article  PubMed  Google Scholar 

  • Chorzelski TP, Jablonska S, Beutner EH, et al. Linear IgA bullous dermatosis. In: Immunopathology and the Skin (Beutner EH, Chorzelski TP, Bean SF, eds). New York, NY: John Wiley & Sons Inc, 1979: 315–323

    Google Scholar 

  • Colbert RL, Allen DM, Eastwood D, Fairley JA (2004) Mortality rate of bullous pemphigoid in a US medical center. J Invest Dermatol; 122: 1091–5

    Article  PubMed  Google Scholar 

  • D’Auria L, Cordiali Fei P, Ameglio F (1999) Cytokines and bullous pemphigoid. Eur Cytokine Netw 10: 123–134

    PubMed  Google Scholar 

  • Delgado JC, Turbay D, Yunis EJ, Yunis JJ, Morton ED, Bhol K, Norman R, Alper CA, Good RA, Ahmed R (1996) A common major histocompatibility complex class II allele HLA-DQβ1 * 0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci 93: 8569–8571

    Article  PubMed  Google Scholar 

  • Diaz LA, Ratrie H, Saunders WS, Futamura S, Squiquera HL, Anhalt GJ, Giudice GK (1990) Isolation of a human epidermal cDNA corresponding to the 180-kDa autoantigen recognized by bullous pemphigoid and herpes gestationis sera. J Clin Invest 86: 1088–1094

    PubMed  Google Scholar 

  • Dimson OG, Giudice GJ, Fu CL, Van den Bergh F, Warren SJ, Janson MM, Fairley JA (2003) Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid. J Invest Dermatol; 120:784–8.

    Article  PubMed  Google Scholar 

  • Di Zenzo G, Grosso F, Terracina M, Mariotti F, De Pita O, Owaribe K, Mastrogiacomo A, Sera F, Borradori L, Zambruno G (2004) Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients. J Invest Dermatol; 122:103–10

    Article  PubMed  Google Scholar 

  • Domolge-Hultsch N, Gammon WR, Briggaman RA, Gil SG, Carter WG, Yancey KB (1992) Epiligrin, the major human keratinocyte ligand, is a target in both an acquired autoimmune and in inherited subepidermal blistering skin disease. J Clin Invest 90: 1628–1633

    PubMed  Google Scholar 

  • Dreno B, Sassolas B, Lacour P, Montpoint S, Lota I, Giordano F, Royer P (1993) Methylprednisolone versus prednisolone methylsulfobenzoate in pemphigoid: a comparative multicenter study. Ann Dermatol Venereol 120:518–21

    PubMed  Google Scholar 

  • Egan CA, Lazarova Z, Darling TN, Yee C, Yancey KB (2003) Anti-epiligrin cicatricial pemphigoid: clinical findings, immunopathogenesis, and significant associations. Medicine; 82:177–86

    Article  PubMed  Google Scholar 

  • Fivenson DP; Breneman DL; Rosen GB; Hersh CS; Cardone S; Mutasim (1994) Nicotinamide and tetracycline therapy of bullous pemphigoid. Arch Dermatol 6: 753–758

    Article  Google Scholar 

  • Fleming TE, Korman NJ (2000) Cicatricial pemphigoid. J Am Acad Dermatol 43: 571–591

    Article  PubMed  Google Scholar 

  • Franzke CW, Tasanen K, Borradori L, Huotari V, Bruckner-Tuderman L (2004) Shedding of collagen XVII/BP180: Structural motifs influence cleavage from cell surface. J Biol Chem. 279:24521–24529.

    Article  PubMed  Google Scholar 

  • Gammon WR, Inman AO III, Wheeler CE, Jr. (1984a) Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods. J Invest Dermatol 83:57–61

    Article  PubMed  Google Scholar 

  • Gammon WR, Briggaman RA, Inman AO III, Queen LL, Wheeler CE (1984b) Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immuno-fluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol 82:139–144

    Article  PubMed  Google Scholar 

  • Gammon WR, Kowalewski C, Chorzelski TP, Kumar V, Briggaman RA, Beutner EH (1990) Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. J Am Acad Dermatol 22: 664–670

    PubMed  Google Scholar 

  • Gammon WR, Briggaman RA (1993) Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen. Dermatol Clin 11: 535–547

    Article  PubMed  Google Scholar 

  • Ghohestani RF, Nicolas JF, Kanitakis J, Claudy A (1997) Linear IgA bullous dermatosis with IgA antibod ies exclusively directed against the 180-and 230-kDa epidermal antigens J Invest Dermatol 108: 854–858

    Article  PubMed  Google Scholar 

  • Giudice GJ, Squiquera HL, Elias PM, Diaz LA (1991) Identification of two collagen domains within the bullous pemphigoid autoantigen, BP180. J Clin Invest 87: 734–738

    PubMed  Google Scholar 

  • Giudice GJ, Emery DJ, Diaz LA (1992) Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol 99: 243–250

    Article  PubMed  Google Scholar 

  • Giudice GJ, Emery DJ, Zelickson BD, Anhalt GJ, Liu Z, Diaz LA (1993) Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol 151: 5742–5750

    PubMed  Google Scholar 

  • Giudice GJ, Wilske KC, Anhalt GJ, Fairley JA, Taylor AF, Emery DJ, Hofman RG, Diaz LA (1994) Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis. J Invest Dermatol 102: 878–881

    Article  PubMed  Google Scholar 

  • Green KJ, Virata MLA, Elgart GW, Stanley JR, Parry DAD (1992) Comparative structural analysis of desmoplakin, bullous pemphigoid antigen and plectin: members of a new gene family involved in organization of intermediate filaments. Int J Biol Macromol 14: 145–153

    PubMed  Google Scholar 

  • Guillaume JC, Vaillant L, Bernard P, Picard C, Prost C, Labeille B, Guillot B, Foldes-Pauwels C, Prigent F, Joly P (1993) Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. Arch Dermatol 129: 49–53

    Article  PubMed  Google Scholar 

  • Guo L, Degenstein L, Dowling J-C, Yu QC, Wollmann R, Perman B, Fuchs E (1995) Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Cell 81: 233–243

    Article  PubMed  Google Scholar 

  • Haase C, Büdinger L, Borradori L, Yee C, Merk HF, Yancey KB, Hertl M (1998) Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2. J Invest Dermatol 110: 282–286

    Article  PubMed  Google Scholar 

  • Hachisuka H, Kurose K, Karashima T, Mori O, Maeyama Y (1996) Serum from elderly individuals contains anti-basement membrane zone antibodies. Arch Dermatol 132: 1201–1205

    Article  PubMed  Google Scholar 

  • Hall RPI, Murray JC, McCord MM, Rico JM, Streilein RD (1993) Rabbits immunized with a peptide encoded for by the 230-kd bullous pemphigoid antigen cDNA develop an enhanced inflammatory response to UVB irradiation: a potential animal model for bullous pemphigoid. J Invest Dermatol 101: 9–14

    Article  PubMed  Google Scholar 

  • Hashimoto T, Ishiko, A, Shimizu H, Tanaka T, Dodd HJ, Bhogal BS, Black MM, Nishikava T (1996) A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantiboies. Br J Dermatol 134: 336–339

    Article  PubMed  Google Scholar 

  • Hirako Y, Usukura J, Uematsu J, Hashimoto T, Kitajima Y, Owaribe K (1998) Cleavage of BP180, a 180-kDa bullous pemphigoid antigen, yields a 120-kDa collagenous extracellular polypeptide. J Biol Chem 273: 9711–9717

    PubMed  Google Scholar 

  • Hirako Y, Nishizawa Y, Sitaru C, Opitz A, Marcus K, Meyer HE, Butt E, Owaribe K, Zillikens D (2003) The 97-kDa (LABD97) and 120-kDa (LAD-1) fragments of bullous pemphigoid antigen 180/type XVII collagen have different N-termini. J Invest Dermatol; 121(6): 1554–6

    Article  PubMed  Google Scholar 

  • Hofmann S, Thoma-Uszynski S, Hunziker T, Bernard P, Koebnick C, Stauber A, Schuler G, Borradori L, Hertl M (2002) Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2-and COOH-terminal regions of the BP180 ectodomain. J Invest Dermatol; 119:1065–73

    Article  PubMed  Google Scholar 

  • Hopkinson SB, Riddelle KS, Jones JCR (1992) Cytoplasmic domain of the 180-kD bullous pemphigoid antigen, a hemidesmosomal component: molecular and cell biologic characterization. J Invest Dermatol 99: 264–270

    Article  PubMed  Google Scholar 

  • Hopkinson SB, Baker SE, Jones JCR (1995) Molecular genetic studies of a human epidermal autoantigen (the 180-kD bullous pemphigoid antigen/BP180): identification of functionally important sequences within the BP180 molecule and evidence for an interaction between BP180 and α6 integrin. J Cell Biol 130:117–125

    Article  PubMed  Google Scholar 

  • Ide A, Hashimoto T, Amagai M, Tanaka M, Nishikawa T (1995) Detection of autoantibodies against the bullous pemphigoid and pemphigus antigens by an enzyme-linked immunosorbent assay using the bacterial recombinant proteins. Exp Dermatol 5: 112–116

    Google Scholar 

  • Joly P, Picard C, Roujeau JC, Delaporte E, Dreno B, Bedane C, Tancrede-Bohin E, Plantin P, D’Incan M, Sassolas B, Saiag P, Lok C, Labeille B, Pauwels C, Chosidow O, Loche F, Guillaume JC, Vaillant L, Bernard P (2000) Comparaison de deux stratégies thérapeutiques: corticothérapie locale versus corticothérapie générale dans le traitement de la pemphigoVde bulleuse (Abstract). Ann Dermatol Venereol suppl.4: 4S4

    Google Scholar 

  • Joly P, Roujeau JC, Benichou J, Picard C, Dreno B, Delaporte E, Vaillant L, D’Incan M, Plantin P, Bedane C, Young P, Bernard P; Bullous Diseases French Study Group (2002) A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med; 346:321–7

    Article  PubMed  Google Scholar 

  • Joly P, Courville P, Lok C, Bernard P, Saiag P, Dreno B, Delaporte E, Bedane C, Picard C, Sassolas B, Plantin P, D’Incan M, Chosidow O, Pauwels C, Lambert D, Loche F, Prost C, Tancrede-Bohin E, Guillaume JC, Roujeau JC, Gilbert D, Tron F, Vaillant L; French Bullous Study Group (2004) Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera. Dermatology; 208:16–20.

    Article  PubMed  Google Scholar 

  • Jonkman MF, de Jong MC, Heeres K, Pas HH, van der Meer JB, Owaribe K, Martinez de Velasco AM, Niessen CM, Sonnenberg A (1995) 180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa. J Clin Invest 95: 1345–1352

    PubMed  Google Scholar 

  • Jenkins RE, Shornick JK, Black MM (1993) Pemphigoid gestationis. J Eur Acad Dermatol 2: 163–173

    Google Scholar 

  • Jordon RE, Beutner EH, Witebsky E, Blumental G, Hale WC, Lever WC (1967) Basement zone antibodies in bullous pemphigoid. J Am Med Assoc 200: 751–756

    Article  Google Scholar 

  • Jung M, Kippes W, Messer G, Zillikens D, Rzany B (1999) Increased risk of bullous pemphigoid in male and very old patients: a population based study on incidence. J Am Acad Dermatol 41: 266–268

    PubMed  Google Scholar 

  • Kawahara Y, Amagai M, Ohata Y, Ishii K, Hasegawa Y, Hsu R, Yee C, Yancey KB, Nishikawa T (1998) A case of cicatricial pemphigoid with simultaneous IgG autoantibodies against the 180 kd bullous pemphigoid antigen and laminin 5. J Am Acad Dermatol 38: 624–627

    PubMed  Google Scholar 

  • Koster J, Geerts D, Favre B, Borradori L, Sonnenberg A (2003) Analysis of the interactions between BP180, BP230, plectin and the integrin alpha6beta4 important for hemidesmosome assembly. J Cell Sci; 116:387–99

    PubMed  Google Scholar 

  • Korman NJ (1987) Bullous pemphigoid. J Am Acad Dermatol 16: 907–24

    PubMed  Google Scholar 

  • Korman NJ (2000) New and emerging therapies in the treatment of blistering diseases. Dermatol Clin 18: 127–137

    Article  PubMed  Google Scholar 

  • Kromminga A, Sitaru C, Hagel C, Herzog S, Zillikens D (2004). Development of an ELISA for the detection of autoantibodies to BP230. Clin Immunol 111:146–52

    Article  PubMed  Google Scholar 

  • Labib RS, Anhalt GJ, Patel HP, Mutasim DF, Diaz LA (1986)Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol 136: 1231–1235

    PubMed  Google Scholar 

  • Laffitte E, Borradori L (2001) Fiche thérapeutique: prise en charge de la pemphigoide bulleuse. Ann Dermatol Venerol. 128: 677–80.

    Google Scholar 

  • Laffitte E, Favre B, Fontao L, Riou S, Jaunin F, Tamm K, Saurat J-H, Borradori L (2001) Plectin, an unusual target in bullous pemphigoid. Br J Dermatol 144: 136–8.

    Article  PubMed  Google Scholar 

  • Laffitte E, Burkhard PR, Fontao L, Jaunin F, Saurat JH, Chofflon M, Borradori L (2004). Bullous pemphigoid antigen 1 isoforms: potential new target auto-antigens in multiple sclerosis?. Br J Dermatol, In press.

    Google Scholar 

  • Leyendeckers H, Tasanen K, Bruckner-Tuderman L, Zillikens D, Sitaru C, Schmitz J, Hunzelmann N (2003) Memory B cells specific for the NC16A domain of the 180 kDa bullous pemphigoid autoantigen can be detected in peripheral blood of bullous pemphigoid patientsand induced in vitro to synthesize autoantibodies. J Invest Dermatol; 120(3):372–8

    Article  PubMed  Google Scholar 

  • Leung CL, Zheng M, Prater SM, Liem RK (2001) The BPAG1 locus: Alternative splicing produces multiple isoforms with distinct cytoskeletal linker domains, including predominant isoforms in neurons and muscles. J Cell Biol 20; 154:691–7

    Google Scholar 

  • Lever WF (1953) Pemphigus. Medicine 32: 1–123

    PubMed  Google Scholar 

  • Li K, Guidice GJ, Tamai K, Do HC, Sawamura D, Diaz LA, Uitto J (1992) Cloning of partial cDNA for mouse 180-kDa bullous pemphigoid antigen (BPAG2), a highly conserved collagenous protein of the cutaneous basement membrane zone. J Invest Dermatol 99: 258–63

    PubMed  Google Scholar 

  • Lin MS, Gharia MA, Swartz SJ, Diaz LA, Giudice GJ (1999) Identification and characterization of epitopes recognized by T lymphocytes and autoantibodies from patients with herpes gestationis J Immunol 162: 4999–4997

    Google Scholar 

  • Lindelöf B, Islam N, Eklund G, Arfors L (1990) Pemphigoid and cancer. Arch Dermatol 126: 66–68

    Article  PubMed  Google Scholar 

  • Liu HH, Su DWP, Rogers RS III (1986) Clinical variants of pemphigoid. Int J Dermatol 25: 17–27

    PubMed  Google Scholar 

  • Liu Z, Diaz LA, Troy JL, Taylor AF, Emery DJ, Fairley JA, Giudice GJ (1993) A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 92: 2480–2488

    PubMed  Google Scholar 

  • Liu Z, Shapiro SD, Zhou X, Twining SS, Senior RM, Giudice GJ, Fairley JA, Diaz LA (2000a) A critical role for neutrophil elastase in experimental bullous pemphigoid. J Clin Invest 105: 113–123

    PubMed  Google Scholar 

  • Liu Z, Chen R, Diaz L, Senior R, Werb Z (2000b) Plasminogen/plasmin in experimental bullous pemphigoid (Abstract). J Invest Dermatol 114: 778

    Google Scholar 

  • Luke MC, Darling TN, Hsu R, Summers RM, Smith JA, Solomon BI, Thomas GR, Yancey KB (1999) Mucosal morbidity in patients with epidermolysis bullosa acquisita. Arch Dermatol 135: 954–959

    Article  PubMed  Google Scholar 

  • Masouyé I, Schmid E, Didierjean L, Abba Z, Saurat JH (1989) Bullous pemphigid and multiple sclerosis: more than a coincidence? Report of three cases. J Am cad Dermatol 21: 63–68

    Google Scholar 

  • McGrath JA, Gatalica B, Christiano AM, Li K, Owaribe K, McMillan JR, Eady RA, Uitto J (1995) Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nature Genet 11: 83–86

    Article  PubMed  Google Scholar 

  • Miller JE, Rico JM, Hall RP (1993) IgG antibodies from patients with bullous pemphigoid bind to fusion proteins encoded by BPAgl cDNA. J Invest Dermatol 101: 779–782

    Article  PubMed  Google Scholar 

  • Morel P, Guillaume JC (1984) Treatment of bullous pemphigoid with prednisolone only: 0.75 mg/kg/day versus 1.25 mg/kg/day. A multicenter randomized study Ann Dermatol Venereol 111:925–928

    Google Scholar 

  • Morrison LH, Labib RS, Zone JJ, Diaz LA, Anhalt GJ (1988) Herpes gestationis autoantibodies recognize a 180-kD human epidermal antigen. J Clin Invest 8: 2023–2026

    Google Scholar 

  • Mueller S, Klaus-Kovtun V, Stanley JR (1989) A 230 kD basic protein is the major bullous pemphigoid antigen. J Invest Dermatol 92: 32–38

    Article  Google Scholar 

  • Nemeth AJ, Klein AD, Gould EW, Schachner LA (1991) Childhood bullous pemphigoid. Clinical and immunologic features, treatment, and prognosis. Arch Dermatol 127: 378–386

    Article  PubMed  Google Scholar 

  • Olivry T, Mirsky ML, Singleton W, Dunston SM, Borillo AK, Xu L, Traczyk T, Rosolia DL, Chan LS (2000) A spontaneously rising porcine model of bullous pemphigoid. Arch Dermatol Res 292: 37–45

    PubMed  Google Scholar 

  • Okazaki A, Miyagawa S, Yamashina Y, Kitamura W, Shirai T (2000) Polymorphisms of HLA-DR and-DQ genes in Japanese patients with bullous pemphigoid. J Dermatol 27: 149–156

    Article  PubMed  Google Scholar 

  • Pas HH, Kloosterhuis GJ, Heeres K, van der Meer JB, Jonkman MF (1997) Bullous pemphigoid and linear IgA dermatosis sera recognize a similar 120-kDa keratinocyte collagenous glycoprotein with antigenic cross-reactivity to BP180. J Invest Dermatol 108: 423–429

    Article  PubMed  Google Scholar 

  • Perriard J, Jaunin F, Favre B, Büdinger L, Hertl M, Saurat J-H, Borradori L (1999) IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domain of the BP antigen 180. J Invest Dermatol 112: 141–147

    Article  PubMed  Google Scholar 

  • Rico MJ, Korman NJ, Stanley JR, Tanaka T, Hall RP (1990): IgG antibodies from patients with bullous pemphigoid bind to localized epitopes on synthetic peptides encoded bullous pemphigoid antigen cDNA. J Immunol 145: 3728–3733

    PubMed  Google Scholar 

  • Rieckhoff-Cantoni L, Bernard P, Didierjean L, Imhof K, Kinloch-de-Loes S, Saurat JH (1992) Frequency of bullous pemphigoid-like antibodies as detected by Western immunoblot analysis in pruritic dermatoses. Arch Dermatol 128: 791–794

    Article  PubMed  Google Scholar 

  • Romagnani S (1992) Human Th1 and Th2 subsets: regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Appl Immunol 98: 279–285

    Google Scholar 

  • Roujeau JC, Lok C, Bastuji-Garin S, Mhalla S, Enginger V, Bernard P (1998) High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol 134:465–469

    Article  PubMed  Google Scholar 

  • Sawamura D, Li K, Chu ML, Uitto J (1991) Human bullous pemphigoid antigen (BPAG1). Amino acid sequences deduced from cloned cDNAs predict biologically important peptide segments and protein domains. J Biol Chem 266: 17784–17790

    PubMed  Google Scholar 

  • Schäcke H, Schumann H, Hammami-Hauasli N, Raghunath M, Bruckner-Tuderman L (1998) Two forms of collagen XVII in keratinocytes. A full-length transmembrane protein and a soluble ectodomain. J Biol Chem 273: 25937–25943

    Article  PubMed  Google Scholar 

  • Schmidt E, Obe K, Brocker EB, Zillikens D (2000a) Serum levels of autoantibdies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 136: 174–178

    Article  PubMed  Google Scholar 

  • Schmidt E, Reimer S, Kruse N, Jainta S, Brocker EB, Marinkovich MP, Giudice GJ, Zillikens D (2000b) Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes. J Invest Dermatol 115:842–848

    Article  PubMed  Google Scholar 

  • Schmidt E, Wehr B, Tabengwa EM, Reimer S, Brocker EB, Zillikens D (2004) Elevated expression and release of tissue-type, but not urokinase-type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 incultured human keratinocytes. Clin Exp Immunol; 135:497–504.

    Article  PubMed  Google Scholar 

  • Skaria M, Jaunin F, Hunziker T, Riou S, Schumann H, Bruckner-Tuderman L, Hertl M, Bernard P, Saurat JH, Favre B, Borradori L (2000) IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomain of the COOH-terminus of BP230. J Invest Dermatol 114: 998–1004

    Article  PubMed  Google Scholar 

  • Shornick JK (1993) Herpes gestationis. Dermatol Clin 11: 527–533

    PubMed  Google Scholar 

  • Stahle-Bäckdahl M, Inoue M, Giudice GJ, Parks WC (1994) 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180 kD in bullous pemphigoid autoantigen. J Clin Invest 93:P2022–2230.

    PubMed  Google Scholar 

  • Stanley JR, Hawley-Nelson P, Yuspa SH, Shevach EM, Katz SI (1981) Characterization of bullous pemphigoid antigen: a umque basement membrane protein of stratified squamous epithelia. Cell 24: 897–903

    Article  PubMed  Google Scholar 

  • Stanley JR, Tanaka T, Mueller S, Klaus-Kovtun V, Roop D (1988) Isolation of complementary DNA for bullous pemphigoid antigen by use of patients’ autoantibodies. J Clin Invest 82: 1864–1870

    PubMed  Google Scholar 

  • Szabolcs P, Reese M, Yancey KB, Hall RP, Kurtzberg J (2002) Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease. Bone Marrow Transplant; 30: 327–9

    Article  PubMed  Google Scholar 

  • Tanaka M, Hashimoto T, Amagai M, Shimizu N, Ikeguchi N, Tsubata T, Hasegawa A, Miki K, Nishikawa T (1991) Characterization of bullous pemphigoid antibodies by use of recombinant bullous pemphigoid antigen proteins. J Invest Dermatol 97: 725–728

    Article  PubMed  Google Scholar 

  • Tanaka M, Hashimoto T, Dykes PJ, Nishikawa T (1996) Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles. Clin Exp Dermatol 21: 23–27

    Article  PubMed  Google Scholar 

  • Taylor G, Venning V, Wojnarowska F, Welch K (1993) Bullous pemphigoid and autoimmunity. J Am Acad Dermatol 29: 181–184

    PubMed  Google Scholar 

  • Thoma-Uszynski S, Uter W, Schwietzke S, Hofmann SC, Hunziker T, Bernard P, Treudler R, Zouboulis CC, Schuler G, Borradori L, Hertl M (2004) BP230-and BP180 specific autoantibodies in bullous pemphigoid. J Invest Dermatol 122: 1413–1422

    Article  PubMed  Google Scholar 

  • Trüeb RM, Didierjean L, Fellas A, Avraam E, Borradori L (1999) Childhood bullous pemphigoid. Report of a case with characterization of the targeted antigens. J Am Acad Dermatol 40: 338–344

    PubMed  Google Scholar 

  • Tyagi S, Bhol K, Natarajan K, Livir-Rallatos C, Foster CS, Ahmed AR (1996) Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization. Proc Natl Acad Sci USA 93: 14714–14719

    Article  PubMed  Google Scholar 

  • Vaillant L, Bernard P, Joly P, Labeille B, Bedane C, Arbeille B, Thomine B, Bertrand B, Lok C, Roujeau JC (1998) Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French bullous study group. Arch Dermatol 134: 1075–1080

    Article  PubMed  Google Scholar 

  • Vanderlugt CJ, Miller SD (1996) Epitope spreading. Curr Opin Immunol 8: 831–836

    Article  PubMed  Google Scholar 

  • Vassileva S (1998) Clin Dermatol 16: 379–387

    Article  PubMed  Google Scholar 

  • Verraes S, Polette M, Borradori L, Hornbeck W, Bernard P (2000) Action des protéases sur l’antigéne cible BP180 au cours de la pemphigoide bulleuse (abstract). Ann Dermatol Venereol 127: 4S2

    Google Scholar 

  • Venning VA, Millard PR, Wojnarowska F (1989) Dapsone as first line therapy for bullous pemphigoid. Br J Dermato 120: 83–92

    Google Scholar 

  • Venning VA, Wojnarowska F (1990) The association of bullous pemphigoid and malignant disease: a case control study. Br J Dermatol 123:439–445

    PubMed  Google Scholar 

  • Wakugawa M, Nakamura K, Hino H, Toyama K, Hattori N, Okochi H, Yamada H, Hirai K, Tamaki K, Furue M (2000) Elevated levels of eotaxin and interleukin-5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia. Br J Dermatol 143: 112–116

    Article  PubMed  Google Scholar 

  • Wojnarowska F, Marsden RA, Bhogal B, Black MM (1988) Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunological overlap. J Am Acad Dermatol 19: 792–805

    PubMed  Google Scholar 

  • Wojnarowska F, Whitehead P, Leigh IM, Bhogal BS, Black MM (1991) Identification of the target antigen in chronic bullous disease of childhood and linear IgA disease of adults. Br J Dermatol 124: 157–162

    PubMed  Google Scholar 

  • Woodley DT, Briggaman RA, O’Keefe EJ, Inman AO, Queen LL, Gammon WR (1984) Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med 310:1007–1013

    PubMed  Google Scholar 

  • Zillikens D, Mascaro JM, Rose PA, et al (1997a) A highly sensistive enzyme-linked immunosorbent assay for the detection of circulating autoantibodies in patients with bullous pemphigoid. J Invest Dermatol 109: 679–683

    Article  PubMed  Google Scholar 

  • Zillikens D, Rose PA, Balding SD, Liu Z, Olague-Marchan M, Diaz LA, Giudice GJ (1997b) Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J Invest Dermatol 109: 573–579

    Article  PubMed  Google Scholar 

  • Zone JJ, Taylor TB, Meyer LJ, Petersen MJ (1998) The 97-kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180-kDa bullous pemphigoid antigen, BPAG2. J Invest Dermatol 110: 207–210

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Emmanuel Laffitte
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luca Borradori
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Dermatology and Allergology, Philipps University, Marburg, Germany

    Michael Hertl MD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Wien

About this chapter

Cite this chapter

Laffitte, E., Borradori, L. (2005). Bullous Pemphigoid: Clinical Features, Diagnostic Markers, and Immunopathogenic Mechanisms. In: Hertl, M. (eds) Autoimmune Diseases of the Skin. Springer, Vienna. https://doi.org/10.1007/3-211-27377-8_4

Download citation

  • DOI: https://doi.org/10.1007/3-211-27377-8_4

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-20686-7

  • Online ISBN: 978-3-211-27377-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation